Revenue
attach_money268M USD
YoY +60.4%
LGNDLigand Pharmaceuticals Incorporated$ --
Ligand Pharmaceuticals Incorporated
LGND
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 12/31/2025
Operating Income
bar_chart47M USD
YoY +308.8%
Net Income
verified124M USD
YoY +3186.6%
EPS
pie_chart6.44USD
YoY +3027.3%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress-7.6%Below Target
Revenue Progress51.7M
Revenue Forecast266.8M
Net Income Progress-13.3M
Net Income Forecast175.1M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.